Vanguard Group Inc Atri Cure, Inc. Transaction History

Vanguard Group Inc

$6.44 Trillion
Q3 2025

A detailed history of Vanguard Group Inc transactions in Atri Cure, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,840,894 shares of ATRC stock, worth $159 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,840,894

Previous 4,906,218 1.33%

Holding current value

$159 Million

Previous $161 Million 6.14%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	SELL	$29.24 - $37.87 $1.91 Million - $2.47 Million	-65,324 Reduced 1.33%	4,840,894 $171 Million
Q2 2025 Aug 11, 2025	BUY	$29.07 - $34.94 $5.58 Million - $6.7 Million	191,847 Added 4.07%	4,906,218 $161 Million
Q1 2025 May 09, 2025	BUY	$30.4 - $42.4 $1.86 Million - $2.59 Million	61,166 Added 1.31%	4,714,371 $152 Million
Q4 2024 Feb 11, 2025	SELL	$27.02 - $38.2 $177,683 - $251,203	-6,576 Reduced 0.14%	4,653,205 $142 Million
Q3 2024 Nov 13, 2024	BUY	$20.34 - $29.5 $769,828 - $1.12 Million	37,848 Added 0.82%	4,659,781 $131 Million

Q2 2024 Aug 13, 2024	SELL	$19.86 - $29.09 $2.6 Million - $3.81 Million	-131,052 Reduced 2.76%	4,621,933 $105 Million
Q1 2024 May 10, 2024	SELL	$28.21 - $37.78 $367,971 - $492,802	-13,044 Reduced 0.27%	4,752,985 $145 Million
Q4 2023 Feb 14, 2024	BUY	$32.99 - $43.25 $2.51 Million - $3.29 Million	76,146 Added 1.62%	4,766,029 $170 Million
Q3 2023 Nov 14, 2023	BUY	$41.12 - $57.73 $1.79 Million - $2.51 Million	43,431 Added 0.93%	4,689,883 $205 Million
Q2 2023 Aug 14, 2023	BUY	$40.44 - $49.6 $4.6 Million - $5.64 Million	113,635 Added 2.51%	4,646,452 $229 Million
Q1 2023 May 15, 2023	BUY	$35.87 - $47.22 $5.13 Million - $6.75 Million	143,002 Added 3.26%	4,532,817 $188 Million
Q4 2022 Feb 10, 2023	BUY	$33.48 - $47.45 $3.19 Million - $4.52 Million	95,352 Added 2.22%	4,389,815 $195 Million
Q3 2022 Nov 14, 2022	BUY	$38.25 - $52.62 $252,947 - $347,976	6,613 Added 0.15%	4,294,463 $168 Million
Q2 2022 Aug 12, 2022	BUY	$35.1 - $66.01 $999,858 - $1.88 Million	28,486 Added 0.67%	4,287,850 $175 Million
Q1 2022 May 13, 2022	BUY	$57.43 - $71.39 $1.44 Million - $1.79 Million	25,066 Added 0.59%	4,259,364 $280 Million
Q4 2021 Feb 14, 2022	BUY	$63.4 - $87.14 $3.13 Million - $4.3 Million	49,371 Added 1.18%	4,234,298 $294 Million
Q3 2021 Nov 12, 2021	SELL	$69.28 - $84.46 $781,963 - $953,300	-11,287 Reduced 0.27%	4,184,927 $291 Million
Q2 2021 Aug 13, 2021	BUY	$64.13 - $80.18 $269 Million - $336 Million	4,196,214 New	4,196,214 $333 Million

Others Institutions Holding ATRC

# of Institutions

243

Shares Held

50.9M

Call Options Held

27.1K

Put Options Held

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.53B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Atri Cure, Inc. Transaction History